Eurofins Webinar on the Latest China Regulatory Updates and Efficacy Claim Evaluation Focus

21 June 2022

on Tuesday 28th June 2022

at 09.00 am EDT (New York) 03.00 pm CEST (Paris)


Part 1 – Latest Regulatory Updates and Compliance Strategies for the Cosmetics Industry in China

In order to regulate the cosmetic industry and promote the healthy development of the cosmetic industries in China, the authorities have reformed the regulatory framework under CSAR. Within a year of our last webinar, a number of new cosmetic policies and regulations were issued successively. This year, a series of regulations will enter the implementation stage. In the upcoming webinar, we will inform you about the latest updates and present the key points of compliance for cosmetics entering the Chinese market.


  • I. Overview of the Cosmetic Market status in China
  • II. Summary of Chinese Cosmetic Regulations and Updates
  • III. Key Points of Compliance Strategies

About the speaker 

Harry Chen, Harry Chen, Senior R&D Manager at Eurofins CPT Shenzhen

With over 16 years of experience in cosmetic product compliance and in-depth kn

owledge of Chinese regulations, Harry provides technical support to the Eurofins Cosmetics & Personal Care laboratory network and to key clients around the globe.


Part 2 – The Trend of Cosmetic Efficacy Evaluation in China under the New Regulation Publication

Following the promulgation of the Cosmetics Supervision and Administration Regulation (CSAR, finalised on June 29th, 2020) by the State Council, on May 1st, 2021, the National Medical Product Administration (NMPA) started to implement its normative regulations, Standards for the Evaluation of Efficacy Claim of Cosmetics and Classification Rules. This stipulates that registering special cosmetics and notifying general cosmetics should be accompanied by efficacy evidence from January 1st, 2022. With this, China officially entered the era of cosmetic efficacy management.

When promoting their products, the enterprises concerned must assess the efficacy claims of their cosmetics and upload the abstracts related to these claims to the website designated by NMPA, as of 2022.

Our team is dedicated to providing comprehensive Cosmetic Clinical Claim Substantiation solutions to help our global customers expedite market access.


  • I. Chinese Relevant New Regulations on Cosmetic Efficacy Claims
  • II. Classification Management of Cosmetic Efficacy Claims in China
  • III. Trends of Cosmetic Efficacy Evaluation Methods
  • IV. Interpretation of Hot Topics related to Cosmetics Claims

About the speaker 

Lexi Liu, Laboratory Manager at Eurofins Guangzhou Cosmetics Clinical laboratory

With over eight years of experience as a Clinical Project Manager, Lexi and the whole cosmetics clinical team at Eurofins China provides comprehensive, high-quality and professional clinical testing services to both global and local cosmetics enterprises.


More information by clicking here



Save time and find easily the methods and the testing suppliers to substantiate your Cosmetics & Personal Care claims.

Don't miss our weekly newsletter

* Receive regular news of what's moving the world of preclinical and clinical testing of the Beauty industry

Save time and easily find the methods and test providers to validate your product claims.